Jason D. Smith - May 17, 2021 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role: General Counsel
Signature: /s/ Jason D. Smith
Stock symbol: URGN
Transactions as of: May 17, 2021
Transactions value $: $39,275
Form type: 4
Date filed: 5/18/2021, 11:35 AM
Next filing: Jun 8, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	URGN	Common Stock	Purchase	$39.3K	+2.5K		$15.71	2.5K	May 17, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.